Biomonitors  ||| S:0 E:12 ||| NNP
of  ||| S:12 E:15 ||| IN
cardiac  ||| S:15 E:23 ||| JJ
injury  ||| S:23 E:30 ||| NN
and  ||| S:30 E:34 ||| CC
performance ||| S:34 E:45 ||| NN
:  ||| S:45 E:47 ||| :
B-type  ||| S:47 E:54 ||| JJ
natriuretic  ||| S:54 E:66 ||| JJ
peptide  ||| S:66 E:74 ||| NN
and  ||| S:74 E:78 ||| CC
troponin  ||| S:78 E:87 ||| NN
as  ||| S:87 E:90 ||| IN
monitors  ||| S:90 E:99 ||| NNS
of  ||| S:99 E:102 ||| IN
hemodynamics  ||| S:102 E:115 ||| NN
and  ||| S:115 E:119 ||| CC
oxygen  ||| S:119 E:126 ||| JJ
transport  ||| S:126 E:136 ||| NN
balance  ||| S:136 E:144 ||| NN
Serum  ||| S:144 E:150 ||| NNP
biomarkers ||| S:150 E:160 ||| NN
,  ||| S:160 E:162 ||| ,
such  ||| S:162 E:167 ||| JJ
as  ||| S:167 E:170 ||| IN
B-type  ||| S:170 E:177 ||| JJ
natriuretic  ||| S:177 E:189 ||| JJ
peptide  ||| S:189 E:197 ||| NN
and  ||| S:197 E:201 ||| CC
troponin ||| S:201 E:209 ||| NN
,  ||| S:209 E:211 ||| ,
are  ||| S:211 E:215 ||| VBP
frequently  ||| S:215 E:226 ||| RB
measured  ||| S:226 E:235 ||| VBN
in  ||| S:235 E:238 ||| IN
the  ||| S:238 E:242 ||| DT
cardiac  ||| S:242 E:250 ||| JJ
intensive  ||| S:250 E:260 ||| JJ
care  ||| S:260 E:265 ||| NN
unit ||| S:265 E:269 ||| NN
.  ||| S:269 E:271 ||| .
A  ||| S:271 E:273 ||| DT
review  ||| S:273 E:280 ||| NN
of  ||| S:280 E:283 ||| IN
the  ||| S:283 E:287 ||| DT
evidence  ||| S:287 E:296 ||| NN
supporting  ||| S:296 E:307 ||| VBG
monitoring  ||| S:307 E:318 ||| NN
of  ||| S:318 E:321 ||| IN
these  ||| S:321 E:327 ||| DT
biomarkers  ||| S:327 E:338 ||| NN
is  ||| S:338 E:341 ||| VBZ
presented ||| S:341 E:350 ||| VBN
.  ||| S:350 E:352 ||| .
A  ||| S:352 E:354 ||| DT
search  ||| S:354 E:361 ||| NN
of  ||| S:361 E:364 ||| IN
MEDLINE ||| S:364 E:371 ||| NNP
,  ||| S:371 E:373 ||| ,
PubMed ||| S:373 E:379 ||| NNP
,  ||| S:379 E:381 ||| ,
and  ||| S:381 E:385 ||| CC
the  ||| S:385 E:389 ||| DT
Cochrane  ||| S:389 E:398 ||| NNP
Database  ||| S:398 E:407 ||| NNP
was  ||| S:407 E:411 ||| VBD
conducted  ||| S:411 E:421 ||| VBN
to  ||| S:421 E:424 ||| TO
find  ||| S:424 E:429 ||| VB
literature  ||| S:429 E:440 ||| NN
regarding  ||| S:440 E:450 ||| VBG
the  ||| S:450 E:454 ||| DT
use  ||| S:454 E:458 ||| NN
of  ||| S:458 E:461 ||| IN
B-type  ||| S:461 E:468 ||| JJ
natriuretic  ||| S:468 E:480 ||| JJ
peptide  ||| S:480 E:488 ||| NN
and  ||| S:488 E:492 ||| CC
troponin  ||| S:492 E:501 ||| NN
in  ||| S:501 E:504 ||| IN
the  ||| S:504 E:508 ||| DT
cardiac  ||| S:508 E:516 ||| JJ
intensive  ||| S:516 E:526 ||| JJ
care  ||| S:526 E:531 ||| NN
setting ||| S:531 E:538 ||| NN
.  ||| S:538 E:540 ||| .
Adult  ||| S:540 E:546 ||| NN
and  ||| S:546 E:550 ||| CC
pediatric  ||| S:550 E:560 ||| JJ
data  ||| S:560 E:565 ||| NNS
were  ||| S:565 E:570 ||| VBD
considered ||| S:570 E:580 ||| VBN
.  ||| S:580 E:582 ||| .
Both  ||| S:582 E:587 ||| DT
B-type  ||| S:587 E:594 ||| JJ
natriuretic  ||| S:594 E:606 ||| JJ
peptide  ||| S:606 E:614 ||| NN
and  ||| S:614 E:618 ||| CC
troponin  ||| S:618 E:627 ||| NNS
have  ||| S:627 E:632 ||| VBP
demonstrated  ||| S:632 E:645 ||| VBN
utility  ||| S:645 E:653 ||| NN
in  ||| S:653 E:656 ||| IN
the  ||| S:656 E:660 ||| DT
intensive  ||| S:660 E:670 ||| JJ
care  ||| S:670 E:675 ||| NN
setting  ||| S:675 E:683 ||| NN
but  ||| S:683 E:687 ||| CC
there  ||| S:687 E:693 ||| EX
is  ||| S:693 E:696 ||| VBZ
no  ||| S:696 E:699 ||| DT
conclusive  ||| S:699 E:710 ||| JJ
evidence  ||| S:710 E:719 ||| NN
at  ||| S:719 E:722 ||| IN
this  ||| S:722 E:727 ||| DT
time  ||| S:727 E:732 ||| NN
that  ||| S:732 E:737 ||| IN
either  ||| S:737 E:744 ||| DT
biomarker  ||| S:744 E:754 ||| NN
can  ||| S:754 E:758 ||| MD
be  ||| S:758 E:761 ||| VB
used  ||| S:761 E:766 ||| VBN
to  ||| S:766 E:769 ||| TO
guide  ||| S:769 E:775 ||| VB
inpatient  ||| S:775 E:785 ||| JJ
management  ||| S:785 E:796 ||| NN
of  ||| S:796 E:799 ||| IN
children  ||| S:799 E:808 ||| NNS
with  ||| S:808 E:813 ||| IN
cardiac  ||| S:813 E:821 ||| JJ
disease ||| S:821 E:828 ||| NN
.  ||| S:828 E:830 ||| .
Although  ||| S:830 E:839 ||| IN
B-type  ||| S:839 E:846 ||| JJ
natriuretic  ||| S:846 E:858 ||| JJ
peptide  ||| S:858 E:866 ||| NN
and  ||| S:866 E:870 ||| CC
troponin  ||| S:870 E:879 ||| JJ
concentrations  ||| S:879 E:894 ||| NNS
can  ||| S:894 E:898 ||| MD
alert  ||| S:898 E:904 ||| VB
clinicians  ||| S:904 E:915 ||| VBN
to  ||| S:915 E:918 ||| TO
myocardial  ||| S:918 E:929 ||| VB
stress ||| S:929 E:935 ||| NN
,  ||| S:935 E:937 ||| ,
injury ||| S:937 E:943 ||| NN
,  ||| S:943 E:945 ||| ,
or  ||| S:945 E:948 ||| CC
hemodynamic  ||| S:948 E:960 ||| JJ
alterations ||| S:960 E:971 ||| NN
,  ||| S:971 E:973 ||| ,
the  ||| S:973 E:977 ||| DT
levels  ||| S:977 E:984 ||| NNS
can  ||| S:984 E:988 ||| MD
also  ||| S:988 E:993 ||| RB
be  ||| S:993 E:996 ||| VB
elevated  ||| S:996 E:1005 ||| VBN
in  ||| S:1005 E:1008 ||| IN
a  ||| S:1008 E:1010 ||| DT
variety  ||| S:1010 E:1018 ||| NN
of  ||| S:1018 E:1021 ||| IN
clinical  ||| S:1021 E:1030 ||| JJ
scenarios ||| S:1030 E:1039 ||| NNS
,  ||| S:1039 E:1041 ||| ,
including  ||| S:1041 E:1051 ||| VBG
sepsis ||| S:1051 E:1057 ||| NN
.  ||| S:1057 E:1059 ||| .
Observational  ||| S:1059 E:1073 ||| JJ
studies  ||| S:1073 E:1081 ||| NNS
have  ||| S:1081 E:1086 ||| VBP
demonstrated  ||| S:1086 E:1099 ||| VBN
that  ||| S:1099 E:1104 ||| IN
perioperative  ||| S:1104 E:1118 ||| JJ
measurement  ||| S:1118 E:1130 ||| NN
of  ||| S:1130 E:1133 ||| IN
these  ||| S:1133 E:1139 ||| DT
biomarkers  ||| S:1139 E:1150 ||| NN
can  ||| S:1150 E:1154 ||| MD
predict  ||| S:1154 E:1162 ||| VB
postoperative  ||| S:1162 E:1176 ||| JJ
mortality  ||| S:1176 E:1186 ||| NN
and  ||| S:1186 E:1190 ||| CC
complications.  ||| S:1190 E:1205 ||| NNP
( ||| S:1205 E:1206 ||| -LRB-
class  ||| S:1206 E:1212 ||| NN
IIb ||| S:1212 E:1215 ||| NN
,  ||| S:1215 E:1217 ||| ,
level  ||| S:1217 E:1223 ||| NN
of  ||| S:1223 E:1226 ||| IN
evidence  ||| S:1226 E:1235 ||| NN
B ||| S:1235 E:1236 ||| NNP
) ||| S:1236 E:1237 ||| -RRB-
:  ||| S:1237 E:1239 ||| :
The  ||| S:1239 E:1243 ||| DT
use  ||| S:1243 E:1247 ||| NN
of  ||| S:1247 E:1250 ||| IN
B-type  ||| S:1250 E:1257 ||| JJ
natriuretic  ||| S:1257 E:1269 ||| JJ
peptide  ||| S:1269 E:1277 ||| NN
and ||| S:1277 E:1280 ||| CC
/ ||| S:1280 E:1281 ||| NNP
or  ||| S:1281 E:1284 ||| CC
troponin  ||| S:1284 E:1293 ||| JJ
measurements  ||| S:1293 E:1306 ||| NNS
in  ||| S:1306 E:1309 ||| IN
the  ||| S:1309 E:1313 ||| DT
evaluation  ||| S:1313 E:1324 ||| NN
of  ||| S:1324 E:1327 ||| IN
hemodynamics  ||| S:1327 E:1340 ||| NN
and  ||| S:1340 E:1344 ||| CC
postoperative  ||| S:1344 E:1358 ||| JJ
outcome  ||| S:1358 E:1366 ||| NN
in  ||| S:1366 E:1369 ||| IN
pediatric  ||| S:1369 E:1379 ||| JJ
cardiac  ||| S:1379 E:1387 ||| JJ
patients  ||| S:1387 E:1396 ||| NNS
may  ||| S:1396 E:1400 ||| MD
be  ||| S:1400 E:1403 ||| VB
beneficial ||| S:1403 E:1413 ||| JJ
.  ||| S:1413 E:1415 ||| .
